Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.alembicpharmaceuticals.com | |
Market Cap | 10,743.16 Cr. | |
Enterprise Value(EV) | 11,296.76 Cr. | 2023-03 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 17.40 | Trailing Twelve Months Ending 2023-03 |
Price-Earning Ratio (PE) | 31.38 | Trailing Twelve Months Ending 2023-03 |
Industry PE | 31.87 | Trailing Twelve Months Ending 2023-03 |
Book Value / Share | 222.34 | Trailing Twelve Months Ending 2023-03 |
Price to Book Value | 2.46 | Calculated using Price: 546.00 |
Dividend Yield | 1.46 | Period Ending 2022-03 |
No. of Shares Subscribed | 19.66 Cr. | 196,563,124 Shares |
FaceValue | 2 | |
About Alembic Pharmaceuticals Ltd. | ||
The company is principally engaged in the manufacturing and selling of Pharmaceuticals products i.e. Formulations and Active Pharmaceutical Ingredients. The company presents an extensive range of branded and generic formulations, in compliance with international and national regulations, that cater to diverse therapeutic segments. |
1 Day |
|
-1.67% |
1 Week |
|
-1.06% |
1 Month |
|
-0.41% |
3 Month |
|
+2.82% |
6 Month |
|
-8.61% |
1 Year |
|
-26.08% |
2 Year |
|
-42.57% |
5 Year |
|
+28.46% |
10 Year |
|
+363.10% |
9 years | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | 39.97 | 36.24 | 58.02 | 23.25 | 20.42 | 24.00 | 26.97 | 26.91 | 10.01 | |
Return on Capital Employed (%) | 43.54 | 37.54 | 65.86 | 28.87 | 22.15 | 22.66 | 23.30 | 26.28 | 11.16 | |
Return on Assets (%) | 18.79 | 18.76 | 33.75 | 14.97 | 12.25 | 13.15 | 14.64 | 17.22 | 7.27 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03* Rs. Cr. |
Shh. Funds | 676 | 885 | 1,597 | 1,902 | 2,220 | 2,719 | 3,219 | 5,067 | 5,238 | 4,370 | |
Non Curr. Liab. | 94 | 72 | 84 | 94 | 576 | 570 | 1,047 | 361 | 162 | 52 | |
Curr. Liab. | 603 | 684 | 944 | 814 | 1,267 | 1,664 | 1,752 | 1,533 | 1,831 | 1,637 | |
Minority Int. | 0 | 0 | -1 | -29 | |||||||
Equity & Liab. | 1,372 | 1,641 | 2,626 | 2,811 | 4,064 | 4,952 | 5,989 | 6,961 | 7,230 | 6,060 | |
Non Curr. Assets | 516 | 750 | 917 | 1,317 | 2,116 | 2,820 | 3,526 | 4,057 | 4,255 | 3,150 | |
Curr. Assets | 857 | 891 | 1,708 | 1,494 | 1,948 | 2,132 | 2,463 | 2,904 | 2,975 | 2,910 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 1,372 | 1,641 | 2,626 | 2,811 | 4,064 | 4,952 | 5,989 | 6,961 | 7,230 | 6,060 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. TTM |
Net Sales | 1,863 | 2,056 | 3,166 | 3,135 | 3,131 | 3,935 | 4,606 | 5,393 | 5,306 | 5,653 | |
Other Income | 4 | 12 | 9 | 3 | 35 | 27 | 14 | 87 | 50 | 3 | |
Total Income | 1,868 | 2,068 | 3,175 | 3,137 | 3,166 | 3,962 | 4,620 | 5,481 | 5,356 | 5,655 | |
Total Expenditure | -1,506 | -1,661 | -2,161 | -2,520 | -2,516 | -3,079 | -3,392 | -3,913 | -4,432 | -4,944 | |
PBIDT | 362 | 407 | 1,014 | 617 | 650 | 883 | 1,228 | 1,568 | 925 | 711 | |
Interest | -10 | -4 | -5 | -5 | -3 | -18 | -27 | -16 | -18 | -50 | |
Depreciation | -40 | -44 | -72 | -83 | -105 | -115 | -157 | -183 | -287 | -275 | |
Taxation | -75 | -76 | -216 | -122 | -120 | -157 | -199 | -253 | -104 | -13 | |
Exceptional Items | -44 | ||||||||||
PAT | 236 | 283 | 720 | 407 | 421 | 593 | 801 | 1,115 | 516 | 373 | |
Minority Interest | 0 | 0 | 1 | 28 | |||||||
Share Associate | 0 | -4 | -8 | -9 | 0 | 32 | 5 | -31 | |||
Other Related Items | |||||||||||
Consolidated Net Profit | 236 | 283 | 720 | 403 | 413 | 584 | 829 | 1,147 | 521 | 342 | |
Adjusted EPS | 12 | 15 | 38 | 21 | 22 | 31 | 44 | 58 | 27 | 17 |
Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | 265 | 240 | 172 | 948 | 329 | 312 | 812 | 449 | 1,463 | 552 | |
Cash Fr. Inv. | -67 | -81 | -256 | -307 | -486 | -884 | -756 | -732 | -839 | -372 | |
Cash Fr. Finan. | -229 | -151 | 87 | -224 | -129 | 503 | 59 | 155 | -597 | -217 | |
Net Change | -31 | 8 | 3 | 417 | -286 | -69 | 115 | -128 | 27 | -37 | |
Cash & Cash Eqvt | 16 | 24 | 27 | 439 | 153 | 84 | 199 | 72 | 98 | 61 |
Thu, 25 May 2023
Compliances-Reg.24(A)-Annual Secretarial Compliance Pursuant to Regulation 24A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 read with SEBI Circular No. CIR/CFD/CMD1/27/2019 dated 8th February 2019 please find enclosed herewith the Annual Secretarial Compliance Report issued by M/s. Samdani Shah & Kabra Practicing Company Secretaries for the financial year ended 31st March 2023. |
Wed, 24 May 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate With reference to the captioned subject please find enclosed herewith the intimation dated 24th May 2023 received from Link lntime India Private Limited Registrar and Share Transfer Agent regarding approval of the request received for issue of Duplicate Share Certificate(s) and issue of letter of confirmation in lieu of the physical share certificate to the registered shareholder(s) in accordance with the provisions of SEBI Circular No. SEBI/HO/MIRSD/MIRSD_RTAMB/P/CIR/2022/8 dated 25th January 2022. |
Tue, 23 May 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we enclose herewith a copy of advertisement related to notice of loss of share certificate(s) for claiming shares from IEPF Authority published by the Company on behalf of the registered shareholder in English language newspaper - Indian Express and Vernacular language (Gujarati) newspaper - Financial Express on 23rd May 2023. |
Fri, 26 May 2023 |
|
|
|
|
|